Indeed, potential therapeutic agents that inhibit LCN2 function show anti-tumor potential and inhibit invasion (Chaudhary et al., 2021, 2023; Guo et al., 2016, 2014; Leng et al., 2009; Yao et al., 2021). This evidence concerns the gene LCN2 and neoplasm.